News | Stroke | February 07, 2025

Study Finds Disparities in Post-Stroke Care for Women

Women are less likely than men to receive post-stroke cardiac monitoring according to a new analysis unveiled at the International Stroke Conference 2025

Getty Images


Feb. 6, 2025 — New findings from the DiVERT Stroke clinical study showed women spent less time in the hospital, saw fewer referrals to cardiology, and were prescribed less frequent post-stroke cardiac monitoring than men when admitted to comprehensive stroke centers following stroke. The data were presented at the International Stroke Conference (ISC) in Los Angeles.

Post-stroke cardiac monitoring is key to informing strategies to help prevent future strokes. Multiple clinical studies have shown that cryptogenic stroke (stroke of unknown cause) patients are at high risk of atrial fibrillation (AF) post-stroke, and for many stroke patients, it could take more than 80 days for AF to appear, reinforcing the importance of long-term, insertable cardiac monitoring. While previous studies have shown disparities in stroke care for women compared to men, the full extent of sex disparities for cardiology consultation and post-stroke cardiac monitoring remains understudied.

The retrospective analysis from the DiVERT Stroke study found that among 2,699 patients, female patients (who accounted for 48% of study participants) were less likely than male patients to receive cardiology referrals during index hospitalization (12.8% vs. 15.5%, p=0.043), had shorter length of stay (6.8 vs. 7.7 days; p=0.025) and were less likely to receive post-stroke cardiac monitoring (19.9% vs. 23.0%, p=0.048). Additionally, the rate of AF detected post-stroke was higher for any type of cardiac monitoring vs. non-monitoring, irrespective of sex (7.4% vs. 3.9%, p=0.015 for women and 8.0% vs. 3.5%, p<0.001 for men), and there were no sex differences for type of cardiac monitoring (external monitors vs. insertable cardiac monitors (ICM)).

“Women have a higher lifetime risk of stroke compared to men, and yet these findings suggest that when it comes to post-stroke care, women are seeing cardiology less often and getting less cardiac monitoring care than their male counterparts,” said David Z. Rose, M.D., professor of vascular neurology at University of South Florida Morsani College of Medicine at Tampa General Hospital and lead investigator in the DiVERT Stroke study who presented the data at the meeting.  “Standardizing care pathways between neurology and cardiology is one way to help  ensure more stroke patients receive guideline-informed cardiac monitoring after a stroke. Further research on this topic is needed and may include artificial intelligence (AI) solutions.”

The DiVERT Stroke study examined in-hospital care pathways for patients with cryptogenic, large-vessel atherosclerotic disease and small vessel disease stroke subtypes. Post-stroke care pathways were assessed using in-person clinician interviews across cardiology and vascular neurology subspecialities, while patient data was collected using electronic medical records and the American Heart Association Get With the Guidelines (AHA GWTG) registry from 2017 to 2019. Baseline demographics and six months post-index stroke discharge data were collected at five comprehensive stroke centers in the United States. The statistical differences could represent sex disparities that impact preventive actions for secondary stroke and long-term outcomes.

Phase II of the DiVERT Stroke study will evaluate opportunities to improve workflow deficiencies, including referral pathways, to help minimize disparities of care.


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now